Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Capicua transcriptional repressor pseudogene 3 (CICP3)
- Target
- CICP3
- Molecular classification
- Pseudogene
01
Overview
Capicua transcriptional repressor pseudogene 3 (CICP3) is a pseudogene related to the capicua transcriptional repressor (CIC), a transcription factor with roles in neurodevelopment, tumor suppression, and cell signaling. Unlike the parental CIC gene, CICP3 is not protein-coding and is classified as a pseudogene; current research does not ascribe biological or therapeutic function to CICP3 itself. Pseudogenes can sometimes regulate their parental counterparts at the RNA level through miRNA competition or serving as sources of regulatory RNAs, but this is not shown for CICP3 specifically. Referencing CICP3 as a therapeutic target is incorrect unless specifically studying non-coding RNA biology or pseudogene network effects in disease[1][2][4].
02
Mechanism of action
None specific for drugs. For pseudogenes, indirect mechanisms might include acting as miRNA “sponges” or decoys, influencing parental gene regulation
03
Biological functions
If transcribed, may act as a competing endogenous RNA, miRNA decoy, or regulator at the RNA levelNo direct protein-coding function
04
Disease associations
None directly established for CICP3; pseudogenes in general may play indirect roles in cancer or other diseases by affecting gene regulation, but specific evidence for CICP3 is lacking
05
Safety considerations
None specific; pseudogenes generally do not present therapeutic safety concerns unless actively transcribed and functional at the RNA level, which is uncommon for CICP3
Beyond the preview
Go deeper on Capicua transcriptional repressor pseudogene 3 (CICP3).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Capicua transcriptional repressor pseudogene 3 (CICP3).